DermvView reveals ambitions to expand into Northern Ireland and the UK in partnership with the NHS in 2023.
Leading Irish dermatological consultancy DermView has opened an advanced €8m clinic in Lucan, Co Dublin.
The business has also revealed ambitious plans for Northern Ireland and the UK in partnership with the NHS.
“From the various projects that DermView has been involved with in Ireland over the past 18 months, the rate of skin cancer has run between 13.5-20% of the examined patient cohort”
The new clinic in Lucan will have four surgical theatres and five consulting rooms and represents an investment of over €8m for DermView, winner of top titles at this year’s Irish Healthcare and HealthTech awards.
Skin in the game
DermView’s technology enables patients, hospitals and clinics to receive rapid, accurate diagnosis from leading Mohs surgeons, consultant dermatologists and plastic surgeons. It provides Ireland’s fastest route to access a Consultant Dermatologist diagnosis.
The business last year raised €1.9m in a three-times oversubscribed funding round.
“The Lucan surgical facility has seen its first patients come through the doors in recent months providing those with skin lesions a rapid end-to-end service from diagnosis to surgical excision and an impressive capacity to facilitate 15,000 dermatology surgeries per year,” said CEO and co-founder Eoin O’Reilly.
DermView is continuing to forge ahead with significant expansion with plans to open further clinical and surgical facilities around Ireland, enabling DermView to facilitate and treat over 25,000 patients nationwide.
In partnership with the NHS, DermView also plans on opening in Northern Ireland and across the UK in 2023
“The new clinic in Lucan will provide a much-needed service for patients,” said Dr Rupert Barry, medical director and co-founder.
“From the various projects that DermView has been involved with in Ireland over the past 18 months, the rate of skin cancer has run between 13.5-20% of the examined patient cohort. When we look at the current 41,000 patients on the public dermatology waiting lists, this means that there are currently several thousand patients with skin cancer on the waiting list and at least 400-500 of these will have a malignant melanoma (which is a form of potentially fatal skin cancer).”
Main image at top: Eoin O’Reilly, CEO and co-founder of DermView with Dr Rupert Barry, consultant dermatologist and co-founder
